摘要 目的：缺血后处理能减轻缺血、再灌注损伤，但在心脏外科手术中的效果尚缺乏大组病例报道。该研究观察了缺血后处理对法洛四联症患儿的心肺保护作用。方法：将105例法洛四联症根治术患者随机分为常规组和处理组，常规组行常规手术，处理组给予缺血后处理，即间断夹闭升主动脉3次。术后以两组患者的ICU治疗时间、输血量、正性肌力药物评分、血流动力学、呼吸功能以及乳酸代谢作为评价指标。结果：与常规组比较，处理组ICU治疗时间明显缩短［（37±21）h vs （54±26）h］，输血量及正性肌力药物计分明显减少［（308±230）mL vs （526±515）mL和（5.9±5.0） vs （10.3±7.7）］，血流动力学和呼吸功能恢复更好，乳酸蓄积明显减少。结论：缺血后处理对法洛四联症根治术患儿有心肺保护作用。［中国当代儿科杂志，2009，11（4）：273-276］
Abstract：OBJECTIVE: Ischemic postconditioning effectively minimizes the ischemic/reperfusion injury, and the large series of case reports on its protective effects in cardiac surgery are limited. A randomized trial was conducted to investigate the effect of ischemic postconditioning on cardiopulmonary protection in children undergoing cardiac surgery for tetralogy of Fallot. METHODS: One hundred and five-children with tetralogy of Fallot undergoing surgery were randomly assigned to control (n=58) and ischemic postconditioning groups (n=47). Ischemic postconditioning was performed by intermittent aortic clamping after reperfusion. After surgery, the duration of intensive care unit (ICU) stay, capacity of blood transfusion, hemodynamics, inotropic scores, respiratory function, and release of blood lactate were assayed. RESULTS: There was a significant decrease in the ICU stay in the postconditioned group compared with the control group (37±21 hrs vs 54±26 hrs; P<0.05 ). The capacity of blood transfusion (308±230 mL vs 526±515 mL; P<0.05) and the inotropic scores (5.9±5.0 vs 10.3±7.7; P<0.05) in the postconditioned group were significantly reduced compared with those in the control group. Blood lactate contents in the postconditioned group was significantly lower that those in the control group 1, 3, 6, 9, 12 and 20 hrs after surgery. The postconditioned group showed more improved hemodynamics and respiratory function than the control group. CONCLUSIONS: Ischemic postconditioning may provide clinical benefits with respects to myocardial and pulmonary protections in children undergoing repair for tetralogy of Fallot.［Chin J Contemp Pediatr, 2009, 11 (4):273-276］
CHEN Ri,LUO Wan-Jun,JIANG Hai-He et al. Cardiopulmonary protection of ischemic postconditioning in cardiac surgery in children with tetralogy of Fallot[J]. CJCP, 2009, 11(04): 273-276.
［1］Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning［J］. Am J Physiol Heart Circ Physiol, 2003, 285(2):H579-H588.
［2］Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways［J］.J Am Coll Cardiol, 2004, 44(5):1103-1110.
［3］Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion［J］. Cardiovasc Res, 2004, 62(1):74-85.
［4］Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L′Huillier I, et al. Postconditioning the human heart［J］. Circulation, 2005, 112(14):2143-2148.
［5］Luo WJ, Li B, Lin GQ, Huang RM. Postconditioning in cardiac surgery for tetralogy of Fallot［J］. J Thorac Cardiovasc Surg, 2007, 133(5):1373-1374.
［6］Luo WJ, Li B, Chen R, Huang R,Lin G. Effect of ischemic postconditioning in adult valve replacement［J］. Eur J Cardiothorac Surg, 2008, 33(2):203-208.
［7］Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans［J］. J Am Coll Cardiol, 2006, 47(11):2277-2282.
［8］Marceau G, Sapin V, Jacomet C, Ughetto S, Cormerais L, Regagnon C, et al. Frequency, risk factors, and outcome of hyperlactatemia in HIVpositive persons: implications for the management of treated patients［J］. Clin Chem, 2003, 49(7):1154-1162.
［9］Munoz R, Laussen PC, Palacio G, Zienko L, Piercey G, Wessel DL. Changes in whole blood lactate levels during cardiopulmonary bypass for surgery for congenital cardiac disease: an early indicator of morbidity and mortality［J］. J Thorac Cardiovasc Surg, 2000, 119(1):155-162.
［10］Maillet JM, Le Besnerais P, Cantoni M, Nataf P, Ruffenach A, Lessana A, et al. Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery［J］. Chest, 2003, 123(5):1361-1366.
［11］Gasparovic H, Plestina S, Sutlic Z, Husedzinovic I, Coric V, Ivancan V, et al. Pulmonary lactate release following cardiopulmonary bypass［J］. Eur J Cardiothorac Surg, 2007, 32(6):882-887.
［12］Ramzy D, Rao V, Weisel RD. Clinical applicability of preconditioning and postconditioning: the cardiothoracic surgeons′s view［J］. Cardiovasc Res, 2006, 70(2):174-180.
［13］Sadat U, Walsh SR, Varty K. Cardioprotection by ischemic postconditioning during surgical procedures［J］. Expert Rev Cardiovasc Ther, 2008, 6(7):999-1006.
［14］Luo W, Li B, Chen R, Huang R, Lin G. Effect of ischemic postconditioning in adult valve replacement［J］. Eur J Cardiothorac Surg, 2008, 33(2):203-208.
［15］Luo W, Li B, Lin G, Chen R, Huang R. Does cardioplegia leave room for postconditioning in paediatric cardiac surgery?［J］.Cardiol Young, 2008, 18(3):282-287.
